secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001437749-25-014093
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Vascular Q1 sales $59.9M (+12% YoY), raises FY guidance, declares $0.20 dividend
--------------------------------------------------------------------------------

- Q1 sales $59.9M, +12% reported (+13% organic); EPS $0.48, +10% YoY.
- FY 2025 sales guidance raised to $242-249M (mid $245M, +13% organic) from prior $239M.
- Quarterly dividend of $0.20/share declared, payable May 29 to holders of record May 15.
- Artegraft received MDR CE Mark on April 29; European launch to begin.
- Ended Elutia porcine patch distribution agreement on April 30 (U.S. hospital sales $5.0M in 2024).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000143774925014093/0001437749-25-014093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000143774925014093/lmat20250501_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-014093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer